<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Mol Hepatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin Mol Hepatol</journal-id>
      <journal-id journal-id-type="publisher-id">CMH</journal-id>
      <journal-title-group>
        <journal-title>Clinical and Molecular Hepatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2287-2728</issn>
      <issn pub-type="epub">2287-285X</issn>
      <publisher>
        <publisher-name>The Korean Association for the Study of the Liver</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26523274</article-id>
      <article-id pub-id-type="pmc">4612293</article-id>
      <article-id pub-id-type="doi">10.3350/cmh.2015.21.3.309</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Liver Pathology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Hye Min</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Haeryoung</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Park</surname>
            <given-names>Young Nyun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Young Nyun Park. Department of Pathology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. Tel: +82-2-2228-1678, Fax: +82-2-362-0860, <email>young0608@yuhs.ac</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <volume>21</volume>
      <issue>3</issue>
      <fpage>309</fpage>
      <lpage>313</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2015 by The Korean Association for the Study of the Liver</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Sarcomatoid cholangiocarcinoma</kwd>
        <kwd>Osteoclast-like giant cells</kwd>
        <kwd>Pathology</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Cholangiocarcinoma (CC) is an adenocarcinoma arising from epithelial cells of varying locations within the biliary tree, and is the second most common primary liver tumor, accounting for approximately 10-15% of all hepatobiliary malignancies.<xref rid="B1" ref-type="bibr">1</xref> This disease has a high prevalence in Southeast and Eastern Asia, including Korea; during the period 2003-2005, the age-standardized incidence rates of intrahepatic CC and extrahepatic CC were reported to be 6.9 and 5.2 out of 100,000 in Korea, respectively.<xref rid="B2" ref-type="bibr">2</xref> Sarcomatoid carcinoma is a rare tumor composed of mixed malignant epithelial and mesenchymal cells, and it can occur in various organs including liver. The prevalence of sarcomatoid CC has been reported to be about 4.5% of surgical and autopsied cases.<xref rid="B3" ref-type="bibr">3</xref> Most sarcomatoid CCs have been reported to have sarcomatous component which show spindle cell or pleomorphic cell differentiation.<xref rid="B4" ref-type="bibr">4</xref> Furthermore, sarcomatoid CC with osteoclast-like giant cells, which morphologically resemble those found in giant cell tumors of the bone is a very rare malignant liver tumor which was first reported as osteoclastoma-like giant cell tumor of the liver by Munoz et al. in 1980.<xref rid="B5" ref-type="bibr">5</xref> To the best of our knowledge, sarcomatoid CC with osteoclast-like giant cells are extremely rare and only 5 cases were reported in the literature so far.<xref rid="B6" ref-type="bibr">6</xref> Here we report a case of sarcomatoid CC with osteoclast-like giant cells, which is associated with hepatolithiasis.</p>
    </sec>
    <sec>
      <title>CASE SUMMARY</title>
      <p>A 67-year-old woman was referred to our hospital for right upper quadrant abdominal pain for 3 weeks. She had no history of alcohol ingestion or smoking, and no remarkable medical history. A computed tomography scan was performed to evaluate the cause of abdominal pain, and revealed distal common bile duct stone or sludge with dilatation of the common bile duct and bilateral intrahepatic ducts and a 6 cm-sized heterogeneous lobulated mass in the left lateral segment of the liver, suggestive of intrahepatic CC with multiple left intrahepatic duct stones (<xref ref-type="fig" rid="F1">Fig. 1A, B</xref>). There was no definite evidence of hepatic artery or portal vein invasion or intrahepatic metastasis. Initial laboratory findings showed normal liver function tests: aspartate aminotransferase 16 IU/L, alanine aminotransferase 22 IU/L, total bilirubin 0.4 mg/dL, direct bilirubin 0.1 mg/dL and elevated gamma-glutamyl transpeptidase 97 IU/L and alkaline phosphatase 151 IU/L. Tumor marker tests revealed elevated carbohydrate antigen 19-9 (1598.0 U/mL) and carcinoembryonic antigen (109.60 ng/mL) levels. Testing for hepatitis B and hepatitis C virus were negative. Under the impression of mass-forming intrahepatic CC, she underwent a left lobectomy of the liver.</p>
    </sec>
    <sec>
      <title>PATHOLOGIC FINDINGS</title>
      <p>On gross examination, the cut surface revealed a single, firm, whitish to tan mass (4.5&#xD7;4.0 cm) with periductal infiltration around the dilated left intrahepatic duct. The duct lumen was distended to about 2 cm in diameter with 3 cm sized black stone impaction (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Microscopically, the tumor showed two distinct components; carcinomatous component and sarcomatous component (<xref ref-type="fig" rid="F3">Fig. 3A</xref>, <xref ref-type="fig" rid="F4">4A</xref>). In the carcinomatous component, the malignant cells formed irregular papillae or fused glands in a prominent fibrous stroma, consistent with features of a typical well-to-moderately differentiated adenocarcinoma. The columnar-to-cuboidal epithelial neoplastic cells had atypical nuclei with some prominent nucleoli, slightly eosinophilic and granular cytoplasm, and some mitosis (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). In the sarcomatous component, there were pleomorphic cells and atypical spindle cells with vesicular nuclei and prominent nucleoli (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). The two components were intermingled. In addition, there were many scattered osteoclast-like giant cells: large multinucleated giant cells containing 10-25 nuclei and about 150-200 &#xB5;m in diameter (<xref ref-type="fig" rid="F4">Fig. 4F</xref>). Perineural invasion and microvessel invasion were seen. In surrounding liver, hepatolithiasis with chronic proliferative cholangitis and microabscess formation was noted (<xref ref-type="fig" rid="F3">Fig. 3D</xref>). The immunohistochemical staining results also demonstrated two distinct patterns. The carcinomatous portion was positive for cytokeratin 19 (<xref ref-type="fig" rid="F4">Fig. 4B</xref>) and negative for vimentin. The sarcomatous portion was positive for vimentin (<xref ref-type="fig" rid="F4">Fig. 4E</xref>) and negative for cytokeratin 19. Both were negative for hepatocyte antigen and alpha-fetoprotein. The osteoclast-like giant cells were positive for CD68 (PG-M1) (<xref ref-type="fig" rid="F4">Fig. 4F</xref>). The immunohistochemical staining with EMT-related markers, E-cadherin and uPAR was conducted. E-cadherin showed total loss in the sarcomatous portion and no loss in the carcinomatous portion (<xref ref-type="fig" rid="F4">Fig. 4C</xref>). uPAR was positive in the sarcomatous portion and peritumoral stroma but negative in the carcinomatous portion (<xref ref-type="fig" rid="F4">Fig. 4D</xref>).</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Sarcomatoid CC is an extremely rare liver primary tumor, and its pathogenesis still remains unclear. Sarcomatous change may be explained by epithelial-mesenchymal transition (EMT), which refers to the biologic process of epithelial phenotype changing to mesenchymal phenotype by undergoing multiple biochemical changes including enhanced migratory capacity, invasiveness, elevated resistance to apoptosis, and increased production of extracellular matrix components. A hallmark of EMT is the loss of epithelial characteristics such as a decrease in the expression of the cell adhesion molecule E-cadherin and acquisition of a mesenchymal phenotype accompanied by increased expression of vimentin. Transforming growth factor &#x3B2; as well as transcription factors such as Twist, Snail, Slug, Sip1, ZEB1 and ZEB2 have a regulatory role in EMT.<xref rid="B7" ref-type="bibr">7</xref> Also, increased uPAR expression has been implicated in the promotion of EMT in various cancers.<xref rid="B8" ref-type="bibr">8</xref> Previous report about 27 cases of sarcomatoid carcinoma originating from various organs, mostly from gastrointestinal tract which included 4 cases of CCs demonstrated that most sarcomatoid carcinomas express EMT-related markers such as Twist1, Snail1, Slug, Sip1 and ZEB1.<xref rid="B9" ref-type="bibr">9</xref> Presenting case showed a positive expression for EMT-related markers: vimentin, uPAR, and loss of E-cadherin, suggesting of EMT.</p>
      <p>Another sarcomatoid carcinoma primarily occurring in the liver is sarcomatoid hepatocellular carcinoma (HCC), and 73 cases of sarcomatoid HCC have been reported in the English literature in the past 20 years.<xref rid="B10" ref-type="bibr">10</xref> Preoperative anticancer treatment such as transcatheter arterial chemoembolization, radiofrequency ablation or percutaneous ethanol injection has been reported to be associated with sarcomatous change in HCC.<xref rid="B11" ref-type="bibr">11</xref> Sarcomatoid HCC without previous therapies was also reported, although there are only a few reports of such cases.<xref rid="B12" ref-type="bibr">12</xref> The present patient with sarcomatoid CC had no history of preoperative treatment, therefore, preoperative treatment is not considered to be necessary for the sarcomatoid change.</p>
      <p>Interestingly, this case showed osteoclast-like giant cells in addition to spindle cells of sarcomatous component. Tumors that contain osteoclast-like giant cells have been reported in several sites, which include the pancreas, lung, thyroid gland, stomach, breast, uterus, kidney, soft tissue, salivary glands,<xref rid="B13" ref-type="bibr">13</xref> and liver.<xref rid="B14" ref-type="bibr">14</xref> Osteoclast-like giant cells which closely resemble those of giant cell tumors of bone may be derived from bone marrow monocytes as they express the monocytic/histiocytic marker, CD68<xref rid="B15" ref-type="bibr">15</xref> and are negative for the epithelial markers. In this case, they were positive for CD68, and were negative for the epithelial marker, cytokeratin 19. These findings support that osteoclast-like giant cells are not epithelial origin but monocytic/histiocytic origin.</p>
      <p>This presenting case showed chronic cholangitis with hepatolithiasis in the non-neoplastic liver. Clinically, hepatolithiasis is considered as a main cause of CC in Korea<xref rid="B16" ref-type="bibr">16</xref> and approximately 10% of patients with hepatolithiasis develop CC.<xref rid="B17" ref-type="bibr">17</xref> Repeated episodes of cholangitis due to hepatolithiasis are considered to induce proliferative epithelial changes and accelerate tumorigenesis.<xref rid="B18" ref-type="bibr">18</xref></p>
      <p>The prognosis of CC is generally unfavorable because of frequent metastasis, low resectability rate and high incidence of recurrence even after curative resection. The median survival is 27 months, and 5-year survival was 31%.<xref rid="B19" ref-type="bibr">19</xref> The outcome of sarcomatoid CC appears to be even worse than conventional CC without sarcomatous change.<xref rid="B20" ref-type="bibr">20</xref> Previous reports have demonstrated that these tumors are consistently very aggressive because of intrahepatic metastasis and frequent widespread metastasis of sarcomatoid cells.<xref rid="B3" ref-type="bibr">3</xref> Therefore, early detection and complete surgical resection might be the only chance to improve the patient's outcome.<xref rid="B21" ref-type="bibr">21</xref> The present case had no intrahepatic metastasis or extrahepatic metastasis at the time of operation, and there was no evidence of cancer recurrence at 6 months after operation.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Conflicts of Interest:</bold> The authors have no conflicts to disclose.</p>
      </fn>
    </fn-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>CC</term>
          <def>
            <p>cholangiocarcinoma</p>
          </def>
        </def-item>
        <def-item>
          <term>EMT</term>
          <def>
            <p>epithelial-mesenchymal transition</p>
          </def>
        </def-item>
        <def-item>
          <term>HCC</term>
          <def>
            <p>hepatocellular carcinoma</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergquist</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>von Seth</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology of cholangiocarcinoma</article-title>
          <source>Best Pract Res Clin Gastroenterol</source>
          <year>2015</year>
          <volume>29</volume>
          <fpage>221</fpage>
          <lpage>232</lpage>
          <pub-id pub-id-type="pmid">25966423</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shin</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>KW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea</article-title>
          <source>J Korean Med Sci</source>
          <year>2010</year>
          <volume>25</volume>
          <fpage>1011</fpage>
          <lpage>1016</lpage>
          <pub-id pub-id-type="pmid">20592891</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakajima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tajima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sugano</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Nagao</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Intrahepatic cholangiocarcinoma with sarcomatous change. Clinicopathologic and immunohistochemical evaluation of seven cases</article-title>
          <source>Cancer</source>
          <year>1993</year>
          <volume>72</volume>
          <fpage>1872</fpage>
          <lpage>1877</lpage>
          <pub-id pub-id-type="pmid">7689920</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malhotra</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mansy</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zaitoun</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Madhusudan</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Intrahepatic sarcomatoid cholangiocarcinoma</article-title>
          <source>J Oncol</source>
          <year>2010</year>
          <volume>2010</volume>
          <fpage>701476</fpage>
          <pub-id pub-id-type="pmid">20454704</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Munoz</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Osteoclastoma-like giant cell tumor of the liver</article-title>
          <source>Cancer</source>
          <year>1980</year>
          <volume>46</volume>
          <fpage>771</fpage>
          <lpage>779</lpage>
          <pub-id pub-id-type="pmid">6994872</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dahm</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical evaluation of a sarcomatoid hepatocellular carcinoma with osteoclastlike giant cells</article-title>
          <source>Diagn Pathol</source>
          <year>2015</year>
          <volume>10</volume>
          <fpage>40</fpage>
          <pub-id pub-id-type="pmid">25928039</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garg</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer</article-title>
          <source>World J Stem Cells</source>
          <year>2013</year>
          <volume>5</volume>
          <fpage>188</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="pmid">24179606</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lester</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Jo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Montel</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Takimoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gonias</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells</article-title>
          <source>J Cell Biol</source>
          <year>2007</year>
          <volume>178</volume>
          <fpage>425</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="pmid">17664334</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sung</surname>
              <given-names>CO</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Sarcomatoid carcinoma represents a complete phenotype with various pathways of epithelial mesenchymal transition</article-title>
          <source>J Clin Pathol</source>
          <year>2013</year>
          <volume>66</volume>
          <fpage>601</fpage>
          <lpage>606</lpage>
          <pub-id pub-id-type="pmid">23533257</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giunchi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vasuri</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Baldin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rosini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Corti</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>D'Errico-Grigioni</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Primary liver sarcomatous carcinoma: report of two cases and review of the literature</article-title>
          <source>Pathol Res Pract</source>
          <year>2013</year>
          <volume>209</volume>
          <fpage>249</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="pmid">23484778</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature</article-title>
          <source>Int J Clin Exp Pathol</source>
          <year>2014</year>
          <volume>7</volume>
          <fpage>8290</fpage>
          <lpage>8294</lpage>
          <pub-id pub-id-type="pmid">25550887</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yokomizo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takiguchi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kainuma</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sarcomatous hepatocellular carcinoma without previous anticancer therapy</article-title>
          <source>J Hepatobiliary Pancreat Surg</source>
          <year>2007</year>
          <volume>14</volume>
          <fpage>324</fpage>
          <lpage>327</lpage>
          <pub-id pub-id-type="pmid">17520211</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosai</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Liver cell carcinoma with osteoclast-like giant cells: nonepitheliogenic giant cells in diverse malignancies</article-title>
          <source>Hepatology</source>
          <year>1990</year>
          <volume>12</volume>
          <fpage>782</fpage>
          <lpage>783</lpage>
          <pub-id pub-id-type="pmid">2170268</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>KB</given-names>
            </name>
          </person-group>
          <article-title>Sarcomatoid hepatocellular carcinoma with mixed osteoclast-like giant cells and chondroid differentiation</article-title>
          <source>Clin Mol Hepatol</source>
          <year>2014</year>
          <volume>20</volume>
          <fpage>313</fpage>
          <lpage>316</lpage>
          <pub-id pub-id-type="pmid">25320737</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>HQ</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Zhuang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Locally advanced undifferentiated carcinoma with osteoclast-like giant cells of the pancreas</article-title>
          <source>World J Gastroenterol</source>
          <year>2015</year>
          <volume>21</volume>
          <fpage>694</fpage>
          <lpage>698</lpage>
          <pub-id pub-id-type="pmid">25593500</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>TY</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Jeon</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Yun</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>HC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study</article-title>
          <source>Am J Gastroenterol</source>
          <year>2008</year>
          <volume>103</volume>
          <fpage>1716</fpage>
          <lpage>1720</lpage>
          <pub-id pub-id-type="pmid">18557716</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tyson</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>El-Serag</surname>
              <given-names>HB</given-names>
            </name>
          </person-group>
          <article-title>Risk factors for cholangiocarcinoma</article-title>
          <source>Hepatology</source>
          <year>2011</year>
          <volume>54</volume>
          <fpage>173</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="pmid">21488076</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haratake</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Horie</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Inokuma</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Giant cell tumor-like cholangiocarcinoma associated with systemic cholelithiasis</article-title>
          <source>Cancer</source>
          <year>1992</year>
          <volume>69</volume>
          <fpage>2444</fpage>
          <lpage>2448</lpage>
          <pub-id pub-id-type="pmid">1314689</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Jong</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Nathan</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sotiropoulos</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Paul</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alexandrescu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Marques</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment</article-title>
          <source>J Clin Oncol</source>
          <year>2011</year>
          <volume>29</volume>
          <fpage>3140</fpage>
          <lpage>3145</lpage>
          <pub-id pub-id-type="pmid">21730269</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaibori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kawaguchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yokoigawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yanagida</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takai</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>AH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intrahepatic sarcomatoid cholangiocarcinoma</article-title>
          <source>J Gastroenterol</source>
          <year>2003</year>
          <volume>38</volume>
          <fpage>1097</fpage>
          <lpage>1101</lpage>
          <pub-id pub-id-type="pmid">14673730</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsou</surname>
              <given-names>YK</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Intrahepatic sarcomatoid cholangiocarcinoma: clinical analysis of seven cases during a 15-year period</article-title>
          <source>Chang Gung Med J</source>
          <year>2008</year>
          <volume>31</volume>
          <fpage>599</fpage>
          <lpage>605</lpage>
          <pub-id pub-id-type="pmid">19241900</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title>Image finding. An axial CT image shows a 6cm-sized heterogeneous lobulated mass in the left lateral segment of the liver (A). Another CT image shows bilateral intrahepatic duct dilatation and multiple left intrahepatic duct stones, measuring 3 cm in the largest one (B).</title>
      </caption>
      <graphic xlink:href="cmh-21-309-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <title>Gross finding. The representative cut surface reveals a single, firm, whitish to tan mass (4.5&#xD7;4.0 cm) with periductal infiltration around the dilated left intrahepatic duct. The lumen of bile duct is distended up to 2 cm in diameter and impacted with pigment stone.</title>
      </caption>
      <graphic xlink:href="cmh-21-309-g002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <title>Microscopic finding. Carcinomatous component and sarcomatous component are intermingled (A. H-E, &#xD7;40). Carcinomatous component shows the features of typical well-to-moderately differentiated adenocarcinoma (B. H-E, &#xD7;200). Sarcomatous component is consisted with pleomorphic cells and atypical spindle cells (C. H-E, &#xD7;200). In surrounding liver, hepatolithiasis with chronic proliferative cholangitis and microabscess formation are noted (D. H-E, &#xD7;100).</title>
      </caption>
      <graphic xlink:href="cmh-21-309-g003"/>
    </fig>
    <fig id="F4" orientation="portrait" position="float">
      <label>Figure 4</label>
      <caption>
        <title>Immunohistochemical finding. Microscopic feature of sarcomatoid cholangiocarcinoma shows intermingled carcinomatous and sarcomatous component (A. H-E, &#xD7;100). Carcinomatous component shows strong expression of cytokeratin 19, but sarcomatous component shows no expression of cytokeratin 19 (B. CK19, &#xD7;200). E-cadherin shows total loss in the sarcomatous portion and no loss in the carcinomatous portion (C. E-cadherin, &#xD7;200). uPAR is positive in the sarcomatous portion but negative in the carcinomatous portion (D. uPAR, &#xD7;200). Sarcomatous component shows diffuse and strong expression of vimentin (E. vimentin, &#xD7;200). Many scattered osteoclast-like giant cells shows positive expression of CD68 (PG-M1) (F. H-E and CD68 (PG-M1), &#xD7;400).</title>
      </caption>
      <graphic xlink:href="cmh-21-309-g004"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
